Interleukin-1 is essential for systemic inflammatory bone loss.
about
Animal Models of Bone Loss in Inflammatory Arthritis: from Cytokines in the Bench to Novel Treatments for Bone Loss in the Bedside-a Comprehensive ReviewGenes influencing spinal bone mineral density in inbred F344, LEW, COP, and DA ratsBiologic therapies and bone loss in rheumatoid arthritis.Gout increases risk of fracture: A nationwide population-based cohort study.Green Tea Extract (GTE) improves differentiation in human osteoblasts during oxidative stress.Discovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis.Cytokine-mediated bone destruction in rheumatoid arthritis.Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice.Wnt10b activates the Wnt, notch, and NFκB pathways in U2OS osteosarcoma cells.Association of stressful life events with accelerated bone loss in older men: the osteoporotic fractures in men (MrOS) studyBone density and hyperlipidemia: the T-lymphocyte connection.Antimyeloma Effects of the Heat Shock Protein 70 Molecular Chaperone Inhibitor MAL3-101The role of IL-1β in the bone loss during rheumatic diseases.Positive regulators of osteoclastogenesis and bone resorption in rheumatoid arthritisDifferential Bone Loss in Mouse Models of Colon Cancer Cachexia.ARTD1 regulates osteoclastogenesis and bone homeostasis by dampening NF-κB-dependent transcription of IL-1βAlleviating effects of morin against experimentally-induced diabetic osteopeniaEngineering of a functional bone organ through endochondral ossificationA Comparative Study of Cathepsin D Expression in Peripheral and Central Giant Cell Granuloma of the Jaws by Immunohistochemistry Technique.Bone effects of biologic drugs in rheumatoid arthritis.Children with nephrotic syndrome have greater bone area but similar volumetric bone mineral density to healthy controlsp38α MAPK regulates proliferation and differentiation of osteoclast progenitors and bone remodeling in an aging-dependent manner.Osteoporosis in inflammatory joint diseases.IL-1β inhibits human osteoblast migration.Regulation of the NLRP3 inflammasome in Porphyromonas gingivalis-accelerated periodontal disease.Expression of RANKL by peripheral neutrophils and its association with bone mineral density in COPD.Double-edged-sword effect of IL-1β on the osteogenesis of periodontal ligament stem cells via crosstalk between the NF-κB, MAPK and BMP/Smad signaling pathways.Inhibition of HDAC activity by ITF2357 ameliorates joint inflammation and prevents cartilage and bone destruction in experimental arthritis.Associations of the IL-1F7 gene polymorphisms with rheumatoid arthritis in Chinese Han population.IL-1β Induces Pathologically Activated Osteoclasts Bearing Extremely High Levels of Resorbing Activity: A Possible Pathological Subpopulation of Osteoclasts, Accompanied by Suppressed Expression of Kindlin-3 and Talin-1.Downregulation of miR-106b attenuates inflammatory responses and joint damage in collagen-induced arthritis.The p55TNFR-IKK2-Ripk3 axis orchestrates arthritis by regulating death and inflammatory pathways in synovial fibroblasts.Paeoniflorin ameliorates collagen-induced arthritis via suppressing NF-κB signaling pathway in osteoclast differentiation.Hyperbaric oxygen therapy ameliorates osteonecrosis in patients by modulating inflammation and oxidative stress
P2860
Q26774874-5737B809-F223-4B60-A269-5DF59A92B42AQ28570822-AC34EB62-C38B-4E2E-9800-B628FB7F8347Q30243911-58C7B1EF-0082-4C57-B896-0BF194590866Q33590612-4B279296-0C66-433D-B09F-7F4D41113225Q33712795-B140C828-3F7E-4CFC-8B23-5A69CF63C3C7Q34047987-DCE2CFAB-9051-403D-A261-B5EA275DE7F6Q34252489-F7398F11-63A5-43EC-86E0-7B29B9F173DAQ34488033-CD16FCBB-EDF3-427C-B12A-1879B2E3B8FFQ34765411-7633AD00-FDE3-4476-8A2F-5586FCD05217Q35091173-C96C0CC0-6917-4ECB-9D6B-B8E633B5A2C7Q35229853-65CFE73B-0EFB-4EE1-A769-B510FDB309F6Q35251058-870EDA2F-80CE-4082-AA09-BBD438441040Q35540844-FE17D52B-7145-4931-A0D4-AC1E865A6C8DQ35617594-2E593070-4762-4518-93E5-2EA3C3A74FC9Q36260536-5E7FA12D-2E9C-4BDE-9F6C-6AB5674F299DQ36588658-FE37101F-8DBC-4836-8D3A-A260992EEB78Q36639407-367F8E07-DC8C-4A77-9A7C-5BA711D276D3Q36673028-92F13B69-EAB7-4BD9-BFDB-1E5B102D1E0CQ36948156-11C5F557-BAA4-4A3C-9D36-A0871E34ED7CQ36995387-C6EF9970-0D54-40CF-96F4-1349CABB20DBQ37142514-CC9C3C69-453F-4240-A0B5-5946ED1FB4C5Q37739585-C35C0C8C-8ED9-4077-A7C9-98412DCCCA75Q37765505-B6920A37-1492-42E5-AAD7-74811E60822AQ40458018-55ACF11C-B915-4771-97C0-CAD492DB959EQ40528540-066C942F-84C0-436E-89F7-B514CDAF7EEBQ40566316-1012B509-B627-400B-BCAF-973BBE77FB9BQ41875487-87C43D1A-966E-4314-881A-37708DF3E216Q42742359-6589D970-B009-499D-B150-6831657D6C85Q43849762-9794CAD0-6389-4749-939A-C793FE4B6EA5Q47399044-347F16CB-24C7-44D8-BF08-19210B869DD8Q47731229-B2800354-5B76-479D-AE1E-425C41AF141AQ49463915-BA0B744D-1CF8-4220-BA67-612FAD0843E3Q49907069-5EB52E27-3015-4025-8612-BC8A3ED9A928Q57023569-B2CAEB67-E066-46A5-913C-29F5BAA14BD2
P2860
Interleukin-1 is essential for systemic inflammatory bone loss.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Interleukin-1 is essential for systemic inflammatory bone loss.
@ast
Interleukin-1 is essential for systemic inflammatory bone loss.
@en
type
label
Interleukin-1 is essential for systemic inflammatory bone loss.
@ast
Interleukin-1 is essential for systemic inflammatory bone loss.
@en
prefLabel
Interleukin-1 is essential for systemic inflammatory bone loss.
@ast
Interleukin-1 is essential for systemic inflammatory bone loss.
@en
P2093
P356
P1476
Interleukin-1 is essential for systemic inflammatory bone loss.
@en
P2093
J H Distler
J S Smolen
P304
P356
10.1136/ARD.2008.104786
P407
P577
2010-01-01T00:00:00Z